.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKinsey
Cantor Fitzgerald
UBS
Teva
Fish and Richardson
QuintilesIMS
Cerilliant
Johnson and Johnson

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,017,609

« Back to Dashboard

Summary for Patent: 5,017,609

Title: Pharmaceutical composition and method of treatment or prophylaxis of cardiac disorders
Abstract:A pharmaceutical composition is disclosed, which contains a short-acting .beta.-blocking compound of the formula ##STR1## wherein R.sub.1 may be an alkyl, cycloalkyl, alkenyl, alkynyl, alkyl carboxymethyl, aryl carboxymethyl, aryl or aralkyl, A may be an alkylene or alkenylene, X may be independently amino, hydrogen, halogen, hydroxy, alkoxy, aryloxy, aralkyl, cyano, amido or trifluoromethyl, n is an integer from 1 to about 4, R may be an alkyl, propargyl, dimethylpropargyl or hydroxyalkyl; or a pharmaceutically acceptable salt thereof in a hydroalcoholic solution further containing a physiologically acceptable buffering agent, ethanol and a physiologically acceptable liquid polyhydric compound. A method for treatment or prophylaxis of cardiac disorders using the composition of the present invention is also disclosed.
Inventor(s): Escobar; Agustin (Aquadilla, PR), Wagenknecht; Dietmar (Zion, IL), Malick; Ahmad W. (Edison, NJ)
Assignee: E. I. Du Pont de Nemours and Company (Wilmington, DE)
Application Number:07/437,293
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Use;

No matches for this query

International Patent Family for Patent: 5,017,609

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia4150785► Subscribe
Australia575153► Subscribe
Canada1242395► Subscribe
Germany3584560► Subscribe
European Patent Office0179808► Subscribe
Italy1184271► Subscribe
Italy8547927► Subscribe
JapanH0720861► Subscribe
JapanS61501775► Subscribe
World Intellectual Property Organization (WIPO)8504580► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Accenture
Chinese Patent Office
Federal Trade Commission
Merck
Express Scripts
Deloitte
Colorcon
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot